Newsroom

Sorted by: Latest

-

Accenture Life Trends 2027 Finds People Want Progress in an AI Era, but on Their Own Terms

NEW YORK--(BUSINESS WIRE)--Accenture today launched its 20th annual Life Trends 2027 report....
-

U.S. Institutions See More Market Upside, but AI’s Next Test Goes Beyond Wall Street, According to Natixis IM 2027 Institutional Outlook Survey

BOSTON--(BUSINESS WIRE)--U.S. institutional investors see room for markets to climb in 2027 and remain confident in AI’s long-term growth potential, but some of the biggest challenges to the technology’s expansion may lie beyond Wall Street. According to the Natixis Investment Managers 2027 Institutional Outlook Survey, 63% expect the S&P 500 to finish 2027 at an all-time high, while 84% believe AI investment still has a long runway for growth. That optimism comes with growing recognition o...
-

Xtrackers (IE) plc UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 17 November 2026 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Co...
-

AM Best Affirms Credit Ratings of Nacional de Reaseguros, S.A.

AMSTERDAM--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of Nacional de Reaseguros, S.A. (Nacional) (Spain). The outlook of these Credit Ratings (ratings) is stable.The ratings reflect Nacional’s balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management.Nacional’s risk-adjusted capita...
-

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 17 November 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, a...
-

Registration opens for Intapp Amplify 2027, with Intapp Celeste on the main stage

PALO ALTO, Calif.--(BUSINESS WIRE)--See Celeste, the expert AI coworker, run firm workflows at Intapp Amplify this March. Register now to join us in New York, London, or virtually....
-

Artos Launches Version 2 of Its Life Sciences AI Platform, Turning Teams’ Knowledge into Data

SAN FRANCISCO--(BUSINESS WIRE)--Artos, the AI platform that turns the knowledge biotech, pharma, and medtech companies create into data they can build on, today announced Version 2 of the Artos platform. V2 brings its Composer and Sentinel agents together on a new knowledge layer shared by medical writing, regulatory, CMC, safety/PV, labeling, and medical affairs teams across programs.Composer drafts and updates study reports, investigator’s brochures, narratives, and CMC documents from a team’s...
-

CorVista Health Launches Clinical Decision Support and Commercial Availability of PCWP Algorithm, Taking the CorVista® Platform from Testing to Guideline-Driven Action

BETHESDA, Md.--(BUSINESS WIRE)--CorVista Health today announced the launch of CorVista Clinical Decision Support (CDS) and the U.S. commercial availability of the CorVista® System Pulmonary Capillary Wedge Pressure (PCWP) Add-On. The two milestones mark the next step for the CorVista platform: moving beyond noninvasive test results to clear, guideline-recommended next steps for patients.A key barrier to bringing advanced cardiopulmonary diagnostics into primary care is clinical fit. Physicians n...
-

Charted Ranked Number 320 Fastest-Growing Company in North America on the 2026 Deloitte Technology Fast 500™

BOSTON--(BUSINESS WIRE)--Charted has ranked number 320 on the Deloitte Technology Fast 500™ 2026 list. This the third year in a row Charted has placed on the list....
-

Xtrackers UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 17 November 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and...